Stammdaten
Revolution Medicines, Inc., ein klinisches Präzisions-Onkologie-Unternehmen, konzentriert sich auf die Entwicklung von Therapien zur Hemmung von Frontier-Zielen in RAS-abhängigen Krebsarten. Das Unternehmen entwickelt RMC-4630, einen Inhibitor von SHP2, der sich in einer Phase 1/2 klinischen Studie zur Behandlung von Festkörpertumoren, wie gynäkologischen und kolorektalen Krebstumoren, befindet. Es entwickelt auch RMC-5845, einen selektiven Inhibitor von SOS1, einem Protein, das RAS (OFF) zu RAS (ON) in Zellen umwandelt; und RMC-5552, einen hyperaktivierten selektiven Inhibitor der mTORC1-Signalisierung in Tumoren. Darüber hinaus entwickelt das Unternehmen RMC-6291, einen mutantenselektiven Inhibitor von KRASG12C(ON) und NRASG12C(ON); und RMC-6236, einen RAS-selektiven Inhibitor mehrerer RAS(ON)-Varianten. Weiterhin entwickelt es RAS(ON)-Inhibitoren, die auf KRASG13C(ON) und KRASG12D(ON) abzielen. Das Unternehmen hat eine Kooperationsvereinbarung mit Sanofi für die Forschung und Entwicklung von SHP2-Inhibitoren, einschließlich RMC-4630. Revolution Medicines, Inc. wurde 2014 gegründet und hat seinen Sitz in Redwood City, Kalifornien.
Unternehmen & Branche
| Name | Revolution Medicines, Inc. |
|---|---|
| Ticker | RVMD |
| CIK | 0001628171 |
| Börse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | 76155X100 |
|---|---|
| ISIN | US76155X1000 |
| Typ | Common Stock |
| Marktkapitalisierung | 36,82 Mrd. USD |
| Beta | 1,40 |
Sitz & Kontakt
| Sitz (Inkorporation) | DE |
|---|---|
| Geschäftsadresse | 700 SAGINAW DR, 94063 REDWOOD CITY, CA |
| Telefon | 650-481-6801 |
| EIN (IRS) | 47-2029180 |
Listing & Historie
| Listing-Börsen | Nasdaq · Nasdaq |
|---|---|
| Fiskaljahr-Ende | 31.12. |
| SEC-Filer-Status | Large accelerated filer |
Bewertung
| KBV (P/B) | 22,57 vs. 3,10 (2021) ▲ |
|---|---|
| FCF-Rendite | -2,5 % vs. -8,2 % (2021) ▲ |
Qualität & Bilanz
| ROIC | -63,2 % vs. -28,0 % (2021) ▼ |
|---|---|
| Zinsdeckungsgrad | -48,8 |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | TTM* | Verlauf |
|---|---|---|---|---|---|---|---|
| Bewertung | |||||||
| KBV (P/B) | 3,10 | 3,14 | 2,59 | 3,59 | 9,62 | 24,55 | |
| KUV (P/S) | 63,50 | 60,87 | 407,85 | – | – | – | |
| FCF-Rendite | -8,2 % | -10,9 % | -7,6 % | -7,0 % | -5,8 % | -2,9 % | |
| Qualität & Bilanz | |||||||
| Operative Marge | -639,7 % | -730,0 % | -4.207,1 % | – | – | – | |
| Nettomarge | -636,6 % | -703,0 % | -3.768,3 % | – | – | – | |
| ROIC | -28,0 % | -33,2 % | -22,8 % | -25,0 % | -63,2 % | -82,8 % | |
| Zinsdeckungsgrad | – | – | – | – | -48,8 | -38,1 | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
TTM* = letzte zwölf Monate (vorläufig, ungeprüft): jüngstes Geschäftsjahr + laufendes YTD − Vorjahres-YTD aus den Quartalsberichten (10-Q); Bewertungs-Multiples gegen die aktuelle Marktkapitalisierung. Kein testierter Jahresabschluss.
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Glück Conviction Score™ ⓘ
ⓘ
RVMD
Revolution Medicines, Inc.
Effektiv
Schwach
Handelsvolumen
Hoch
Insider
0,0
Keine Insider-Käufe
Institutionell
78,4
181 neu, 176 erhöht, 4004,6M $ netto
Aktivist
0,0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,71% (Stand: 30.06.2026)
Score-Verlauf (90 Tage)
Konviktions-Verlauf — oben stark · Mitte neutral · unten schwach
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (24 Monate)
Indexierte Darstellung (Start = 100) — die Kursform bleibt sichtbar, absolute Kurse sind angemeldeten Mitgliedern vorbehalten.
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 161.40 | +14.6 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 106.43 | +73.8 % vs SMA200 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 179.17 | EMA50: 162.72 | |
| MACD-Histogramm | Bärisch | 10 % | -0.750 | Bearisch | |
| RSI(14) | Neutral | 10 % | 62.6 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 67.7 | Neutral | |
| ADX(14)+DI | Bullisch | 10 % | 44.1 | +DI: 29.2 / −DI: 16.2 | |
| Z-Score(60) | Bärisch | 5 % | 1.57 | Extrem überkauft | |
| 52W-Position | Bullisch | 5 % | 95.2 % | Hoch 192.62 / Tief 34.70 | |
| Bollinger(20,2σ) | Neutral | 5 % | 62.5 % | Upper 203.31 / Mid 178.83 / Lower 154.35 | |
| LinReg-Slope(60) | Bullisch | 10 % | +0.8597 | R²=0.76 / annualisiert +137.0 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-06-29 | Patel Sushil | Director | Open Market Sale | -1.100 | 185,90 | -204.489,01 | -22,6% | |
| 2026-06-29 | Patel Sushil | Director | Open Market Sale | -600 | 190,55 | -114.327,00 | -12,6% | |
| 2026-06-29 | Patel Sushil | Director | Open Market Sale | -858 | 186,92 | -160.373,67 | -17,7% | |
| 2026-06-29 | Patel Sushil | Director | Open Market Sale | -881 | 192,61 | -169.692,85 | -18,8% | |
| 2026-06-29 | Patel Sushil | Director | Open Market Sale | -900 | 184,59 | -166.128,21 | -18,4% | |
| 2026-06-29 | Patel Sushil | Director | Open Market Sale | -100 | 188,57 | -18.857,00 | -2,1% | |
| 2026-06-29 | Patel Sushil | Director | Open Market Sale | -300 | 183,17 | -54.951,99 | -6,1% | |
| 2026-06-29 | Patel Sushil | Director | Open Market Sale | -300 | 187,83 | -56.348,01 | -6,2% | |
| 2026-06-29 | Patel Sushil | Director | Open Market Sale | -541 | 191,87 | -103.799,56 | -11,5% | |
| 2026-06-24 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -4.553 | 167,35 | -761.921,79 | -84,3% | |
| 2026-06-24 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -5.651 | 169,24 | -956.398,41 | -105,8% | |
| 2026-06-24 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -9.496 | 168,20 | -1.597.188,27 | -176,7% | |
| 2026-06-24 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -300 | 170,32 | -51.096,00 | -5,7% | |
| 2026-06-17 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -29.600 | 160,12 | -4.739.679,28 | -524,3% | |
| 2026-06-16 | Cislini Jeff | Officer, General Counsel | Open Market Sale | -2.157 | 156,12 | -336.748,90 | -37,2% | |
| 2026-06-16 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -10.020 | 156,12 | -1.564.310,38 | -173,0% | |
| 2026-06-16 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -4.615 | 156,12 | -720.490,11 | -79,7% | |
| 2026-06-16 | Kelsey Stephen Michael | Officer, See Remarks | Open Market Sale | -4.175 | 156,12 | -651.797,66 | -72,1% | |
| 2026-06-16 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -2.722 | 156,12 | -424.956,46 | -47,0% | |
| 2026-06-15 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -60.400 | 160,17 | -9.674.304,24 | -1070,1% | |
| 2026-06-11 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -1.315 | 144,28 | -189.727,28 | -21,0% | |
| 2026-06-11 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -4.600 | 149,64 | -688.357,34 | -76,1% | |
| 2026-06-11 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -1.800 | 148,72 | -267.701,58 | -29,6% | |
| 2026-06-11 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -885 | 145,15 | -128.457,31 | -14,2% | |
| 2026-06-11 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -700 | 146,04 | -102.225,97 | -11,3% | |
| 2026-06-11 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -500 | 147,27 | -73.636,00 | -8,1% | |
| 2026-06-11 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -200 | 150,17 | -30.034,00 | -3,3% | |
| 2026-05-26 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -2.000 | 154,06 | -308.121,80 | -34,1% | |
| 2026-05-26 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -700 | 153,30 | -107.311,61 | -11,9% | |
| 2026-05-26 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -421 | 154,82 | -65.177,41 | -7,2% | |
| 2026-04-27 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -400 | 134,34 | -53.734,00 | -5,9% | |
| 2026-04-27 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -1.671 | 131,66 | -220.007,03 | -24,3% | |
| 2026-04-27 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -1.049 | 132,88 | -139.387,76 | -15,4% | |
| 2026-04-15 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -120.000 | 150,09 | -18.010.488,00 | -1992,2% | |
| 2026-03-25 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -11.036 | 96,43 | -1.064.200,38 | -117,7% | |
| 2026-03-25 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -3.128 | 94,16 | -294.520,28 | -32,6% | |
| 2026-03-25 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -21.086 | 95,49 | -2.013.415,69 | -222,7% | |
| 2026-03-25 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -1.800 | 93,22 | -167.801,40 | -18,6% | |
| 2026-03-25 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -400 | 97,21 | -38.882,84 | -4,3% | |
| 2026-03-19 | Cislini Jeff | Officer, General Counsel | Open Market Sale | -1.163 | 97,44 | -113.322,72 | -12,5% | |
| 2026-03-17 | Kelsey Stephen Michael | Officer, See Remarks | Open Market Sale | -4.302 | 99,48 | -427.964,68 | -47,3% | |
| 2026-03-17 | Wang Xiaolin | Officer, See Remarks | Open Market Sale | -2.010 | 99,48 | -199.955,60 | -22,1% | |
| 2026-03-17 | Cislini Jeff | Officer, General Counsel | Open Market Sale | -1.795 | 99,48 | -178.567,32 | -19,8% | |
| 2026-03-17 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -2.753 | 99,48 | -273.869,54 | -30,3% | |
| 2026-03-17 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -4.583 | 99,48 | -455.918,67 | -50,4% | |
| 2026-03-17 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -12.871 | 99,48 | -1.280.412,23 | -141,6% | |
| 2026-03-17 | Wei Lin | Officer, Chief Medical Officer | Open Market Sale | -2.073 | 99,48 | -206.222,87 | -22,8% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -21.329 | 101,60 | -2.167.075,46 | -239,7% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -100 | 98,29 | -9.829,00 | -1,1% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -100 | 98,31 | -9.831,00 | -1,1% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -200 | 102,08 | -20.416,00 | -2,3% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -400 | 100,12 | -40.049,00 | -4,4% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -600 | 100,19 | -60.115,98 | -6,6% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -700 | 98,17 | -68.719,56 | -7,6% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -800 | 102,00 | -81.598,64 | -9,0% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -851 | 102,20 | -86.971,69 | -9,6% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -1.700 | 101,47 | -172.506,31 | -19,1% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -2.100 | 101,63 | -213.431,61 | -23,6% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -3.500 | 99,76 | -349.150,20 | -38,6% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -3.620 | 100,73 | -364.659,25 | -40,3% | |
| 2026-01-21 | Cislini Jeff | Officer, General Counsel | Open Market Sale | -908 | 115,60 | -104.964,80 | -11,6% | |
| 2026-01-07 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -1.700 | 102,90 | -174.930,00 | -19,4% | |
| 2026-01-07 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -10.000 | 98,00 | -980.000,00 | -108,4% | |
| 2026-01-07 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -53.096 | 100,02 | -5.310.470,77 | -587,4% | |
| 2026-01-07 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -20.204 | 101,79 | -2.056.621,73 | -227,5% | |
| 2025-12-16 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -15.394 | 76,82 | -1.182.525,52 | -130,8% | |
| 2025-12-16 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -3.104 | 77,09 | -239.288,60 | -26,5% | |
| 2025-12-16 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -4.847 | 76,82 | -372.333,45 | -41,2% | |
| 2025-12-16 | Kelsey Stephen Michael | Officer, See Remarks | Open Market Sale | -5.447 | 76,82 | -418.423,29 | -46,3% | |
| 2025-12-16 | Cislini Jeff | Officer, General Counsel | Open Market Sale | -2.688 | 76,82 | -206.483,83 | -22,8% | |
| 2025-11-25 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -3.000 | 75,00 | -225.000,00 | -24,9% | |
| 2025-11-25 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -60.000 | 75,08 | -4.504.962,00 | -498,3% | |
| 2025-11-25 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -5.418 | 74,00 | -400.932,00 | -44,3% | |
| 2025-11-18 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -20.000 | 70,38 | -1.407.586,00 | -155,7% | |
| 2025-11-18 | Cislini Jeff | Officer, General Counsel | Open Market Sale | -13.388 | 70,14 | -939.007,54 | -103,9% | |
| 2025-11-12 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -20.000 | 65,07 | -1.301.410,00 | -144,0% | |
| 2025-11-11 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -10.000 | 64,00 | -640.000,00 | -70,8% | |
| 2025-11-07 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -30.000 | 60,31 | -1.809.306,00 | -200,1% | |
| 2025-10-17 | Cislini Jeff | Officer, General Counsel | Open Market Sale | -12.000 | 55,00 | -660.000,00 | -73,0% | |
| 2025-10-17 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -10.000 | 55,00 | -550.000,00 | -60,8% | |
| 2025-10-16 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -10.000 | 50,47 | -504.701,00 | -55,8% | |
| 2025-10-13 | Kelsey Stephen Michael | Officer, See Remarks | Open Market Sale | -25.000 | 48,54 | -1.213.540,00 | -134,2% | |
| 2025-09-24 | Cislini Jeff | Officer, General Counsel | Open Market Sale | -1.799 | 44,26 | -79.623,74 | -8,8% | |
| 2025-09-16 | Kelsey Stephen Michael | Officer, See Remarks | Open Market Sale | -5.367 | 45,82 | -245.942,24 | -27,2% | |
| 2025-09-16 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -2.320 | 45,82 | -106.313,77 | -11,8% | |
| 2025-09-16 | Cislini Jeff | Officer, General Counsel | Open Market Sale | -1.869 | 45,82 | -85.646,74 | -9,5% | |
| 2025-09-16 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -4.775 | 45,82 | -218.813,90 | -24,2% | |
| 2025-09-16 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -13.411 | 45,82 | -614.557,73 | -68,0% | |
| 2025-09-16 | Wei Lin | Officer, Chief Medical Officer | Open Market Sale | -2.160 | 45,82 | -98.981,78 | -10,9% | |
| 2025-09-15 | Kelsey Stephen Michael | Officer, See Remarks | Open Market Sale | -23.682 | 45,92 | -1.087.418,24 | -120,3% | |
| 2025-09-15 | Kelsey Stephen Michael | Officer, See Remarks | Open Market Sale | -1.318 | 46,93 | -61.854,00 | -6,8% | |
| 2025-09-11 | Kelsey Stephen Michael | Officer, See Remarks | Open Market Sale | -55.941 | 44,48 | -2.488.518,60 | -275,3% | |
| 2025-09-11 | Kelsey Stephen Michael | Officer, See Remarks | Open Market Sale | -44.059 | 43,58 | -1.919.963,45 | -212,4% | |
| 2025-09-03 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -5.238 | 40,17 | -210.432,46 | -23,3% | |
| 2025-09-02 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -4.762 | 40,02 | -190.560,00 | -21,1% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
⚠ Vorläufige Daten: Erst 1018 von typischerweise 8355 Fonds (12 %) haben für das aktuelle 13F-Quartal eingereicht — Werte können sich in den kommenden Wochen noch deutlich ändern.
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 13.724.881 | 0 | 13.724.881 | 1.323.275.359 | Neu | +100,0% | |
| BlackRock, Inc. | 11.212.706 | 0 | 11.212.706 | 1.090.435.565 | Neu | +100,0% | |
| Janus Henderson Group Ltd. | 9.766.496 | 0 | 9.766.496 | 949.537.126 | Neu | +100,0% | |
| BAKER BROS. ADVISORS LP | 9.555.357 | 0 | 9.555.357 | 929.258.468 | Neu | +100,0% | |
| FMR LLC | 8.464.314 | 0 | 8.464.314 | 823.154.497 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 8.362.284 | 0 | 8.362.284 | 813.232.119 | Neu | +100,0% | |
| Nextech Invest, Ltd. | 7.601.087 | 0 | 7.601.087 | 739.205.711 | Neu | +100,0% | |
| Paradigm Biocapital Advisors LP | 6.655.703 | 0 | 6.655.703 | 647.267.117 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 6.027.819 | 0 | 6.027.819 | 586.205.399 | Neu | +100,0% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5.975.611 | 0 | 5.975.611 | 533.398.170 | Neu | +100,0% | |
| STATE STREET CORP | 4.402.662 | 0 | 4.402.662 | 428.158.880 | Neu | +100,0% | |
| UBS Group AG | 4.395.177 | 0 | 4.395.177 | 427.346.386 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 3.338.142 | 0 | 3.338.142 | 323.930.219 | Neu | +100,0% | |
| Alphabet Inc. | 3.292.525 | 0 | 3.292.525 | 320.198.056 | Neu | +100,0% | |
| BVF INC/IL | 2.856.782 | 0 | 2.856.782 | 277.822.050 | Neu | +100,0% | |
| Integral Health Asset Management, LLC | 2.750.000 | 0 | 2.750.000 | 267.437.500 | Neu | +100,0% | |
| Casdin Capital, LLC | 2.577.333 | 0 | 2.577.333 | 250.645.634 | Neu | +100,0% | |
| Woodline Partners LP | 2.506.570 | 0 | 2.506.570 | 243.763.933 | Neu | +100,0% | |
| Holocene Advisors, LP | 2.468.644 | 0 | 2.468.644 | 240.075.629 | Neu | +100,0% | |
| Vestal Point Capital, LP | 2.375.000 | 0 | 2.375.000 | 230.968.750 | Neu | +100,0% | |
| Avoro Capital Advisors LLC | 2.344.444 | 0 | 2.344.444 | 227.997.179 | Neu | +100,0% | |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2.297.000 | 0 | 2.297.000 | 223.383.250 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2.229.085 | 0 | 2.229.085 | 216.778.516 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 2.185.500 | 0 | 2.185.500 | 212.539.875 | Neu | +100,0% | |
| Darwin Global Management, Ltd. | 2.211.018 | 0 | 2.211.018 | 204.983.479 | Neu | +100,0% | |
| Logos Global Management LP | 2.000.000 | 0 | 2.000.000 | 194.500.000 | Neu | +100,0% | |
| Alyeska Investment Group, L.P. | 1.885.821 | 0 | 1.885.821 | 183.396.092 | Neu | +100,0% | |
| Caligan Partners LP | 1.881.708 | 0 | 1.881.708 | 182.996.103 | Neu | +100,0% | |
| NATIONAL BANK OF CANADA /FI/ | 1.749.000 | 0 | 1.749.000 | 170.090.250 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.735.476 | 0 | 1.735.476 | 168.775.041 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 1.579.793 | 0 | 1.579.793 | 153.635.129 | Neu | +100,0% | |
| Caption Management, LLC | 2.067.685 | 0 | 2.067.685 | 151.664.156 | Neu | +100,0% | |
| TWO SIGMA INVESTMENTS, LP | 1.558.807 | 0 | 1.558.807 | 151.593.981 | Neu | +100,0% | |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.556.578 | 0 | 1.556.578 | 151.377.191 | Neu | +100,0% | |
| Bellevue Group AG | 1.544.456 | 0 | 1.544.456 | 150.198.346 | Neu | +100,0% | |
| Rock Springs Capital Management LP | 1.209.465 | 0 | 1.209.465 | 117.620.471 | Neu | +100,0% | |
| Polar Capital Holdings Plc | 1.133.930 | 0 | 1.133.930 | 110.274.693 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 1.133.546 | 0 | 1.133.546 | 110.237.382 | Neu | +100,0% | |
| Siren, L.L.C. | 1.110.980 | 0 | 1.110.980 | 108.042.805 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 2.658.843 | 0 | 2.658.843 | 107.633.731 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 1.004.453 | 0 | 1.004.453 | 97.683.055 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 954.256 | 0 | 954.256 | 92.801.396 | Neu | +100,0% | |
| a16z Capital Management, L.L.C. | 921.099 | 0 | 921.099 | 89.576.878 | Neu | +100,0% | |
| BOOTHBAY FUND MANAGEMENT, LLC | 850.795 | 0 | 850.795 | 82.739.814 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 844.614 | 0 | 844.614 | 82.072.300 | Neu | +100,0% | |
| AIHC Capital Management Ltd | 828.974 | 0 | 828.974 | 80.617.722 | Neu | +100,0% | |
| MIC Capital Management UK LLP | 795.733 | 0 | 795.733 | 77.385.034 | Neu | +100,0% | |
| GENERAL ATLANTIC, L.P. | 707.791 | 0 | 707.791 | 68.832.675 | Neu | +100,0% | |
| MORGAN STANLEY | 708.009 | 0 | 708.009 | 68.642.387 | Neu | +100,0% | |
| Nearwater Capital Markets, Ltd | 678.000 | 0 | 678.000 | 65.935.500 | Neu | +100,0% |
Top-Fondshalter (Stand: 30.06.2026) ⓘ
⚠ Vorläufige Daten: Erst 1018 von typischerweise 8355 Fonds (12 %) haben für dieses Quartal eingereicht. Vollständigkeit erwartet bis 14.08.2026. Auswertungen (NEW/INC/DEC) sind noch zu konservativ — viele Spätfiler erscheinen aktuell als „Exits".
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) | Stimmkontrolle | Verlauf |
|---|---|---|---|---|---|---|---|
| Assenagon Asset Management S.A. | 200.486 | 0 | +100,0% | 37.547.018 | 49,30 | 100 % | 1 Q |
| TEMA ETFS LLC | 71.735 | 98.178 | -26,9% | 13.434.531 | 17,64 | 100 % | 7 Q |
| Wedmont Private Capital | 40.281 | 40.231 | +0,1% | 7.527.713 | 9,88 | 0 % | 11 Q |
| Sandy Cove Advisors, LLC | 27.008 | 27.008 | 0,0% | 5.058.058 | 6,64 | 0 % | 7 Q |
| Spire Wealth Management | 16.140 | 0 | +100,0% | 3.022.899 | 3,97 | – | 7 Q |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 14.600 | 0 | +100,0% | 2.466.529 | 3,24 | 1 % | 2 Q |
| QRG CAPITAL MANAGEMENT, INC. | 8.083 | 6.140 | +31,6% | 1.514.012 | 1,99 | 100 % | 2 Q |
| Connective Portfolio Management, LLC | 4.500 | 0 | +100,0% | 842.760 | 1,11 | 100 % | 1 Q |
| E. Ohman J:or Asset Management AB | 4.000 | 4.000 | 0,0% | 749.120 | 0,98 | 100 % | 2 Q |
| PensionDanmark Pensionsforsikringsaktieselskab | 4.000 | 0 | +100,0% | 749.120 | 0,98 | 0 % | 1 Q |
| GAMMA Investing LLC | 2.100 | 1.599 | +31,3% | 393.288 | 0,52 | 100 % | 11 Q |
| Legal Advantage Investments, Inc. | 2.000 | 0 | +100,0% | 374.560 | 0,49 | 0 % | 1 Q |
| MOODY ALDRICH PARTNERS LLC | 1.952 | 0 | +100,0% | 365.571 | 0,48 | 100 % | 1 Q |
| Avior Wealth Management, LLC | 1.769 | 3.327 | -46,8% | 331.298 | 0,44 | 0 % | 5 Q |
| NorthCrest Asset Manangement, LLC | 1.370 | 0 | +100,0% | 261.848 | 0,34 | 1 % | 1 Q |
| PSP Research LLC | 1.200 | 0 | +100,0% | 224.736 | 0,30 | 0 % | 2 Q |
| RVW Wealth, LLC | 1.194 | 0 | +100,0% | 223.612 | 0,29 | – | 1 Q |
| WADDELL & ASSOCIATES, LLC | 1.193 | 0 | +100,0% | 223.425 | 0,29 | 0 % | 1 Q |
| Valeo Financial Advisors, LLC | 1.101 | 0 | +100,0% | 206.171 | 0,27 | 100 % | 1 Q |
| Barnes Dennig Private Wealth Management LLC | 508 | 0 | +100,0% | 95.138 | 0,12 | – | 1 Q |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 30.06.2026 | vorl. | 46 | 0,7 | 76 |
| 31.03.2026 | ✓ | 515 | 229,6 | 20.614 |
| 31.12.2025 | ✓ | 394 | 215,9 | 15.843 |
| 30.09.2025 | ✓ | 335 | 222,6 | 9.546 |
| 30.06.2025 | ✓ | 311 | 200,1 | 6.644 |
| 31.03.2025 | ✓ | 296 | 209,4 | 6.842 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) |
|---|---|---|
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 13.724.881 | 1.323.275.359 |
| VANGUARD CAPITAL MANAGEMENT LLC | 8.362.284 | 813.232.119 |
| Darwin Global Management, Ltd. | 2.211.018 | 204.983.479 |
| NATIONAL BANK OF CANADA /FI/ | 1.749.000 | 170.090.250 |
| Nearwater Capital Markets, Ltd | 678.000 | 65.935.500 |
| Qube Research & Technologies Ltd | 553.290 | 53.807.453 |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 479.080 | 46.590.530 |
| SAMLYN CAPITAL, LLC | 371.948 | 36.171.943 |
| Melqart Asset Management (UK) Ltd | 270.363 | 26.292.802 |
| Trails Edge Capital Partners, LP | 245.000 | 23.826.250 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5.975.611 | 3.270.056 | +120.9 % | 533.398.170 |
| BlackRock, Inc. | 11.212.706 | 2.286.050 | +25.6 % | 1.090.435.565 |
| Vestal Point Capital, LP | 2.375.000 | 2.080.000 | +705.1 % | 230.968.750 |
| Alyeska Investment Group, L.P. | 1.885.821 | 1.646.724 | +688.7 % | 183.396.092 |
| UBS Group AG | 4.387.677 | 1.299.740 | +42.1 % | 426.617.011 |
| TWO SIGMA INVESTMENTS, LP | 1.558.807 | 1.137.072 | +269.6 % | 151.593.981 |
| LMR Partners LLP | 3.968.024 | 816.319 | +25.9 % | 19.512.563 |
| Sculptor Capital LP | 958.822 | 780.715 | +438.3 % | 1.697.115 |
| Holocene Advisors, LP | 2.468.644 | 560.696 | +29.4 % | 240.075.629 |
| WORLDQUANT MILLENNIUM ADVISORS LLC | 622.304 | 528.294 | +562.0 % | 60.519.064 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| Bellevue Group AG | 1.544.456 | -3.461.263 | -69.1 % | 150.198.346 |
| Janus Henderson Group Ltd. | 9.766.496 | -2.537.006 | -20.6 % | 949.537.126 |
| GENERAL ATLANTIC, L.P. | 707.791 | -2.105.137 | -74.8 % | 68.832.675 |
| Lunate Capital Ltd | 999.050 | -1.647.150 | -62.2 % | 54.200.613 |
| T. Rowe Price Investment Management, Inc. | 664.047 | -1.536.329 | -69.8 % | 64.579 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.556.578 | -1.288.435 | -45.3 % | 151.377.191 |
| Jefferies Financial Group Inc. | 2.490 | -1.138.705 | -99.8 % | 242.153 |
| JANE STREET GROUP, LLC | 33.603 | -1.056.813 | -96.9 % | 3.267.891 |
| WELLINGTON MANAGEMENT GROUP LLP | 6.027.819 | -959.820 | -13.7 % | 586.205.399 |
| CITADEL ADVISORS LLC | 400.053 | -902.308 | -69.3 % | 38.905.155 |
Zusätzlich aktuell von 212 Mutual Funds/ETFs gehalten (N-PORT). Alle Fondsgesellschaften & ihre 4-Quartals-Bewegungen →
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Δ-Balken |
|---|---|---|---|---|---|---|
| 15.05.2026 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 4,90 % | 9.766.496 | -1,20 pp | |
| 27.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -8,93 pp | |
| 17.02.2026 | Baker Bros. Advisors (GP) LLC (+3) | Passiv (13G/A) | 4,90 % | 9.455.357 | -0,10 pp | |
| 10.02.2026 | Wellington Investment Advisors Holdings LLP (+2) | Passiv (13G/A) | 3,60 % | 6.987.639 | -1,90 pp | |
| 09.02.2026 | Farallon Capital F5 Master I, L.P. (+1) | Passiv (13G/A) | 0,20 % | 370.466 | -0,10 pp | |
| 09.02.2026 | Farallon Capital Institutional Partners III, L.P. | Passiv (13G/A) | 0,10 % | 164.197 | 0,00 pp | |
| 09.02.2026 | Farallon Capital Institutional Partners, L.P. | Passiv (13G/A) | 0,70 % | 1.377.579 | 0,00 pp | |
| 09.02.2026 | Farallon Capital Institutional Partners II, L.P. | Passiv (13G/A) | 0,20 % | 332.755 | 0,00 pp | |
| 09.02.2026 | Four Crossings Institutional Partners V, L.P. (+1) | Passiv (13G/A) | 0,10 % | 238.987 | 0,00 pp | |
| 09.02.2026 | Fried, Richard B (+2) | Passiv (13G/A) | Ausstieg | 0 | Neu | |
| 09.02.2026 | Farallon Capital Offshore Investors II, L.P. | Passiv (13G/A) | 1,30 % | 2.482.796 | 0,00 pp | |
| 09.02.2026 | Farallon Healthcare Partners (GP), L.L.C. (+1) | Passiv (13G/A) | 4,40 % | 8.420.065 | -0,30 pp | |
| 09.02.2026 | Farallon Capital Partners, L.P. | Passiv (13G/A) | 0,50 % | 1.057.562 | 0,00 pp | |
| 09.02.2026 | Farallon Partners, L.L.C. | Passiv (13G/A) | 7,40 % | 14.225.683 | -0,20 pp | |
| 09.02.2026 | Roberts, Jr., Thomas G. (+14) | Passiv (13G/A) | 7,50 % | 14.596.149 | -0,40 pp | |
| 09.02.2026 | Farallon Capital (AM) Investors, L.P. | Passiv (13G/A) | 0,10 % | 151.742 | 0,00 pp | |
| 14.11.2025 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 6,10 % | 11.356.054 | +0,40 pp | |
| 05.11.2025 | Abigail P. Johnson (+1) | Passiv (13G) | 5,00 % | 9.401.687 | Neu | |
| 14.08.2025 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 5,70 % | 10.590.727 | +0,20 pp | |
| 14.08.2025 | Baker Bros. Advisors (GP) LLC (+3) | Passiv (13G) | 5,00 % | 9.364.972 | Neu | |
| 12.08.2025 | Wellington Management Company LLP | Passiv (13G/A) | 5,20 % | 10.259.738 | -1,39 pp | |
| 12.08.2025 | Wellington Investment Advisors Holdings LLP (+2) | Passiv (13G/A) | 5,50 % | 10.259.738 | -1,33 pp | |
| 17.07.2025 | BlackRock, Inc. | Passiv (13G/A) | 4,50 % | 8.399.214 | Neu | |
| 15.05.2025 | Farallon Capital F5 Master I, L.P. (+1) | Passiv (13G/A) | 0,30 % | 421.785 | +0,10 pp | |
| 15.05.2025 | Farallon Healthcare Partners (GP), L.L.C. (+1) | Passiv (13G/A) | 4,70 % | 7.890.785 | +0,80 pp | |
| 15.05.2025 | Farallon Capital Institutional Partners, L.P. | Passiv (13G/A) | 0,70 % | 1.179.934 | +0,10 pp | |
| 15.05.2025 | Farallon Capital Institutional Partners II, L.P. | Passiv (13G/A) | 0,20 % | 297.041 | 0,00 pp | |
| 15.05.2025 | Farallon Capital Offshore Investors II, L.P. | Passiv (13G/A) | 1,30 % | 2.111.561 | +0,20 pp | |
| 15.05.2025 | Farallon Capital (AM) Investors, L.P. | Passiv (13G/A) | 0,10 % | 128.580 | 0,00 pp | |
| 15.05.2025 | Four Crossings Institutional Partners V, L.P. (+1) | Passiv (13G/A) | 0,10 % | 204.302 | 0,00 pp | |
| 15.05.2025 | Farallon Capital Institutional Partners III, L.P. | Passiv (13G/A) | 0,10 % | 133.463 | 0,00 pp | |
| 15.05.2025 | Farallon Partners, L.L.C. | Passiv (13G/A) | 7,60 % | 12.840.260 | +1,10 pp | |
| 15.05.2025 | Farallon Capital Partners, L.P. | Passiv (13G/A) | 0,50 % | 894.594 | 0,00 pp | |
| 15.05.2025 | Roberts, Jr., Thomas G. (+16) | Passiv (13G/A) | 7,90 % | 13.262.045 | +1,10 pp | |
| 15.05.2025 | Farallon Capital F5 Master I, L.P. (+1) | Passiv (13G/A) | 0,20 % | 408.085 | 0,00 pp | |
| 15.05.2025 | Farallon Capital Institutional Partners III, L.P. | Passiv (13G/A) | 0,10 % | 110.363 | 0,00 pp | |
| 15.05.2025 | Farallon Capital Institutional Partners, L.P. | Passiv (13G/A) | 0,60 % | 1.016.234 | +0,10 pp | |
| 15.05.2025 | Farallon Capital Partners, L.P. | Passiv (13G/A) | 0,50 % | 816.794 | +0,20 pp | |
| 15.05.2025 | Farallon Capital Institutional Partners II, L.P. | Passiv (13G/A) | 0,20 % | 280.341 | +0,10 pp | |
| 15.05.2025 | Farallon Healthcare Partners (GP), L.L.C. (+1) | Passiv (13G/A) | 3,90 % | 6.564.585 | +1,00 pp |
Finanzkennzahlen (SEC XBRL) ⓘ
Währung:
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | – | -453.816.000 $ | -2,29 $ | 2.253.737.000 $ | 1.499.917.000 $ |
| 2025-12-31 | 10-K | 0 $ | -1.131.301.000 $ | -5,95 $ | 2.354.508.000 $ | 1.631.297.000 $ |
| 2025-09-30 | 10-Q | – | -305.206.000 $ | -1,61 $ | 2.251.920.000 $ | 1.596.904.000 $ |
| 2025-06-30 | 10-Q | – | -247.787.000 $ | -1,31 $ | 2.429.568.000 $ | 1.865.369.000 $ |
| 2025-03-31 | 10-Q | – | -213.416.000 $ | -1,13 $ | 2.365.353.000 $ | 2.078.150.000 $ |
| 2024-12-31 | 10-K | 0 $ | -600.093.000 $ | -3,58 $ | 2.558.301.000 $ | 2.265.204.000 $ |
| 2024-09-30 | 10-Q | 0 $ | -156.288.000 $ | -0,94 $ | 1.762.999.000 $ | 1.566.304.000 $ |
| 2024-06-30 | 10-Q | 0 $ | -133.233.000 $ | -0,81 $ | 1.808.437.000 $ | 1.618.848.000 $ |
| 2024-03-31 | 10-Q | 0 $ | -116.003.000 $ | -0,70 $ | 1.908.362.000 $ | 1.725.467.000 $ |
| 2023-12-31 | 10-K | 11.580.000 $ | -436.367.000 $ | -3,86 $ | 2.061.705.000 $ | 1.826.194.000 $ |
| 2023-09-30 | 10-Q | 0 $ | -108.434.000 $ | -0,99 $ | 984.232.000 $ | 837.458.000 $ |
| 2023-06-30 | 10-Q | 3.824.000 $ | -98.298.000 $ | -0,92 $ | 1.073.709.000 $ | 930.835.000 $ |
| 2023-03-31 | 10-Q | 7.014.000 $ | -68.098.000 $ | -0,72 $ | 1.073.248.000 $ | 952.218.000 $ |
| 2022-12-31 | 10-K | 35.380.000 $ | -248.705.000 $ | -3,08 $ | 811.930.000 $ | 685.188.000 $ |
| 2022-09-30 | 10-Q | 3.356.000 $ | -73.329.000 $ | -0,87 $ | 825.910.000 $ | 681.419.000 $ |
| 2022-06-30 | 10-Q | 9.116.000 $ | -61.222.000 $ | -0,82 $ | 632.802.000 $ | 498.841.000 $ |
| 2022-03-31 | 10-Q | 7.578.000 $ | -57.647.000 $ | -0,78 $ | 682.774.000 $ | 550.993.000 $ |
| 2021-12-31 | 10-K | 29.390.000 $ | -187.091.000 $ | -2,57 $ | 737.988.000 $ | 602.568.000 $ |
| 2021-09-30 | 10-Q | 1.101.000 $ | -52.940.000 $ | -0,72 $ | 734.976.000 $ | 638.204.000 $ |
| 2021-06-30 | 10-Q | 8.698.000 $ | -44.299.000 $ | -0,60 $ | 774.046.000 $ | 685.006.000 $ |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| Collaboration Revenue | 35,4 Mio. | 29,4 Mio. | – | – | – | 100,0 % | +20,4% | |
| Collaboration Revenue Related Party | – | – | 43,0 Mio. | 50,0 Mio. | 19,4 Mio. | – | – | |
| Collaboration Revenues Other | – | – | – | – | 745.000 | – | – |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 06.05.2026 | – | -2,29 |
| Q3 2025 | 30.09.2025 | 05.11.2025 | – | -1,61 |
| Q2 2025 | 30.06.2025 | 06.08.2025 | – | -1,31 |
| Q1 2025 | 31.03.2025 | 07.05.2025 | – | -1,13 |
| Q3 2024 | 30.09.2024 | 06.11.2024 | 0 USD | -0,94 |
| Q2 2024 | 30.06.2024 | 07.08.2024 | 0 USD | -0,81 |
| Q1 2024 | 31.03.2024 | 08.05.2024 | 0 USD | -0,70 |
| Q3 2023 | 30.09.2023 | 06.11.2023 | 0 USD | -0,99 |
| Q2 2023 | 30.06.2023 | 08.08.2023 | 3,8 Mio. USD | -0,92 |
Einreichungs-Historie (10-K / 10-Q / 20-F / 6-K)
SEC-Einreichungs-Historie der letzten sechs Jahre (Datum = US-Kalendertag,
SEC/ET): Quartalsberichte (10-Q) und Jahresberichte (10-K); ausländische
Emittenten (ADR/Foreign Private Issuer) reichen stattdessen Jahresberichte
(20-F/40-F) und Zwischenmitteilungen (6-K) ein — dort liegt im SEC-Index
keine Berichtsperiode vor, Periode und Verzögerung bleiben leer. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht (US) | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 06.05.2026 | 10-Q | 31.03.2026 | 36 Tage | SEC » |
| 25.02.2026 | 10-K | 31.12.2025 | 56 Tage | SEC » |
| 05.11.2025 | 10-Q | 30.09.2025 | 36 Tage | SEC » |
| 06.08.2025 | 10-Q | 30.06.2025 | 37 Tage | SEC » |
| 07.05.2025 | 10-Q | 31.03.2025 | 37 Tage | SEC » |
| 26.02.2025 | 10-K | 31.12.2024 | 57 Tage | SEC » |
| 06.11.2024 | 10-Q | 30.09.2024 | 37 Tage | SEC » |
| 07.08.2024 | 10-Q | 30.06.2024 | 38 Tage | SEC » |
| 08.05.2024 | 10-Q | 31.03.2024 | 38 Tage | SEC » |
| 26.02.2024 | 10-K | 31.12.2023 | 57 Tage | SEC » |
| 06.11.2023 | 10-Q | 30.09.2023 | 37 Tage | SEC » |
| 08.08.2023 | 10-Q | 30.06.2023 | 39 Tage | SEC » |
| 08.05.2023 | 10-Q | 31.03.2023 | 38 Tage | SEC » |
| 27.02.2023 | 10-K | 31.12.2022 | 58 Tage | SEC » |
| 07.11.2022 | 10-Q | 30.09.2022 | 38 Tage | SEC » |
| 09.08.2022 | 10-Q | 30.06.2022 | 40 Tage | SEC » |
| 09.05.2022 | 10-Q | 31.03.2022 | 39 Tage | SEC » |
| 28.02.2022 | 10-K | 31.12.2021 | 59 Tage | SEC » |
| 10.11.2021 | 10-Q | 30.09.2021 | 41 Tage | SEC » |
| 11.08.2021 | 10-Q | 30.06.2021 | 42 Tage | SEC » |
| 10.05.2021 | 10-Q | 31.03.2021 | 40 Tage | SEC » |
| 02.03.2021 | 10-K | 31.12.2020 | 61 Tage | SEC » |
| 12.11.2020 | 10-Q | 30.09.2020 | 43 Tage | SEC » |
| 10.08.2020 | 10-Q | 30.06.2020 | 41 Tage | SEC » |
Kapitalerhöhungen & Emissions-Historie
Emissions-Historie aus den finalen SEC-Prospekten: Börsengang (424B4) und Kapitalerhöhungen (424B5, Folge-/Sekundärplatzierungen). Volumen = Brutto-Erlös (bei Börsengängen zusätzlich der Ausgabepreis). Wiederholte Kapitalerhöhungen deuten auf Verwässerung der Altaktionäre hin.
| Datum (US) | Art | Volumen | |
|---|---|---|---|
| 15.04.2026 | Kapitalerhöhung | $500,0 Mio | SEC » |
| 15.04.2026 | Kapitalerhöhung | $1,50 Mrd · $142,00/Aktie | SEC » |
| 13.04.2026 | Kapitalerhöhung | $250,0 Mio | SEC » |
| 13.04.2026 | Kapitalerhöhung | $750,0 Mio | SEC » |
| 25.02.2026 | Kapitalerhöhung | $1,00 Mrd | SEC » |
| 05.12.2024 | Kapitalerhöhung | – | SEC » |
| 02.12.2024 | Kapitalerhöhung | – | SEC » |
| 07.08.2024 | Kapitalerhöhung | – | SEC » |
| 03.03.2023 | Kapitalerhöhung | – | SEC » |
| 01.03.2023 | Kapitalerhöhung | – | SEC » |
| 20.07.2022 | Kapitalerhöhung | – | SEC » |
| 19.07.2022 | Kapitalerhöhung | – | SEC » |
| 10.11.2021 | Kapitalerhöhung | – | SEC » |
| 05.02.2021 | Börsengang | – | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). Beträge in US-Dollar.
Proxy-/Governance-Filings
Proxy-Statements (SEC DEF-14A-Familie) der letzten sechs Jahre: reguläre HV-Einladungen zur Aktionärsversammlung, Aktivisten-Proxy-Fights (contested / Non-Management-Solicitation) und M&A-Abstimmungen.
| Datum (US) | Kategorie | Form | |
|---|---|---|---|
| 28.04.2026 | HV-Einladung | DEFA14A | SEC » |
| 27.04.2026 | HV-Einladung | DEF 14A | SEC » |
| 29.04.2025 | HV-Einladung | DEFA14A | SEC » |
| 29.04.2025 | HV-Einladung | DEF 14A | SEC » |
| 25.04.2024 | HV-Einladung | DEFA14A | SEC » |
| 25.04.2024 | HV-Einladung | DEF 14A | SEC » |
| 01.11.2023 | HV-Einladung | DEFA14A | SEC » |
| 29.09.2023 | M&A-Abstimmung | DEFM14A | SEC » |
| 26.04.2023 | HV-Einladung | DEFA14A | SEC » |
| 26.04.2023 | HV-Einladung | DEF 14A | SEC » |
| 26.04.2022 | HV-Einladung | DEFA14A | SEC » |
| 26.04.2022 | HV-Einladung | DEF 14A | SEC » |
| 03.05.2021 | HV-Einladung | DEFA14A | SEC » |
| 28.04.2021 | HV-Einladung | DEFA14A | SEC » |
| 28.04.2021 | HV-Einladung | DEF 14A | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). HV-Termine und Vergütung stehen im Dokument (SEC-Link).
Übernahmen & Fusionen (M&A)
M&A-relevante SEC-Filings der letzten sechs Jahre: Übernahmeangebote (Tender Offers), Fusionen (425/S-4), Aktienrückkauf-Angebote (Self-Tender) und Going-Private-Transaktionen. Geführt nach dem einreichenden Emittenten.
| Datum (US) | Kategorie | Form | Deal-Konditionen | SEC |
|---|---|---|---|---|
| 01.11.2023 | Fusion | 425 | Ziel: EQRx · Aktientausch · Umtausch 0,1112 Akt./Ziel-Aktie | SEC » |
| 23.10.2023 | Fusion | 425 | Ziel: EQRx, Inc. | SEC » |
| 27.09.2023 | Fusion | S-4/A | Ziel: EQRx, Inc. | SEC » |
| 13.09.2023 | Fusion | S-4 | Ziel: Revolution Medicines, Inc. · Aktientausch · Umtausch 0,0869 Akt./Ziel-Aktie | SEC » |
| 01.08.2023 | Fusion | 425 | Ziel: EQRx, Inc. | SEC » |
| 01.08.2023 | Fusion | 425 | Ziel: EQRx, Inc. · Aktientausch · Umtausch 0,7692 Akt./Ziel-Aktie | SEC » |
| 01.08.2023 | Fusion | 425 | Ziel: EQRx, Inc. · Aktientausch | SEC » |
| 01.08.2023 | Fusion | 425 | Ziel: EQRx, Inc. · Aktientausch | SEC » |
| 01.08.2023 | Fusion | 425 | Ziel: EQRx, Inc. · Aktientausch | SEC » |
| 01.08.2023 | Fusion | 425 | Ziel: EQRx, Inc. · Aktientausch | SEC » |
| 01.08.2023 | Fusion | 425 | Ziel: EQRx · Aktientausch · Umtausch 0,7692 Akt./Ziel-Aktie | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). Deal-Konditionen aus dem Dokument extrahiert (Tender: SC TO-T/-I/SC 14D9; Fusion: 425/S-4 — Gegenpartei + Umtauschverhältnis), ohne Gewähr — Original siehe SEC-Link.
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Tags | Schwere | Filing | Auszug |
|---|---|---|---|---|---|
| 08.03.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02(f) of Form 8-K, the table below updates the “Non-equity incentive plan compensation” and… |
| 20.03.2020 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02(f) of Form 8-K, the table below updates the “Non-equity incentive plan compensation” and… |
8-K-Ereignisse (KI)
🔒 Die vollständige KI-Einordnung je 8-K ist Teil des Kunden-Abos — freischalten.
| Datum | Ereignis | Sentiment | Materialität | Zusammenfassung | Filing |
|---|---|---|---|---|---|
| 06.05.2026 | Quartalszahlen | 0,00 | 70 | Revolution Medicines gab am 6. Mai 2026 die Finanzergebnisse für das erste Quartal 2026 bekannt. Details finden sich in der beiliegenden Pre… 🔒 | SEC |
| 17.04.2026 | Finanzierung/Anleihe | 0,20 | 78 | Revolution Medicines unterzeichnete am 14. April 2026 eine Underwriting-Vereinbarung zur Ausgabe von Schuldverschreibungen im Wert von 500 M… 🔒 | SEC |
| 25.02.2026 | Quartalszahlen | 0,00 | 55 | Revolution Medicines kündigte seine Jahresergebnisse für das Jahr 2025 an. Die vollständige Pressemitteilung wurde eingereicht. | SEC |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-06-29 | 167.291 | 182,08 | 30.460.345 |
| 2026-06-24 | 4 | 169,51 | 678 |
| 2026-06-22 | 16.264 | 162,99 | 2.650.869 |
| 2026-06-18 | 36 | 157,77 | 5.680 |
| 2026-06-17 | 31 | 156,58 | 4.854 |
| 2026-06-15 | 616 | 153,87 | 94.784 |
| 2026-06-12 | 3 | 149,23 | 448 |
| 2026-06-10 | 33 | 149,55 | 4.935 |
| 2026-06-05 | 995 | 155,69 | 154.912 |
| 2026-06-04 | 89 | 155,99 | 13.883 |
| 2026-05-26 | 3 | 151,56 | 455 |
| 2026-05-20 | 33 | 147,30 | 4.861 |
| 2026-05-15 | 3 | 149,47 | 448 |
| 2026-05-13 | 194 | 145,72 | 28.270 |
| 2026-05-05 | 5.713 | 147,90 | 844.953 |
| 2026-04-23 | 496 | 141,50 | 70.184 |
| 2026-04-21 | 1 | 146,23 | 146 |
| 2026-04-20 | 2.345 | 148,63 | 348.537 |
| 2026-04-16 | 10 | 152,54 | 1.525 |
| 2026-04-15 | 3.375 | 147,01 | 496.159 |
| 2026-04-02 | 1 | 98,64 | 99 |
| 2026-03-25 | 252.389 | 95,52 | 24.108.197 |
| 2026-03-20 | 1.324 | 99,29 | 131.460 |
| 2026-03-12 | 48.958 | 99,59 | 4.875.727 |
| 2026-03-05 | 1.937 | 101,19 | 196.005 |
| 2026-02-23 | 12 | 101,83 | 1.222 |
| 2026-02-20 | 35.325 | 102,74 | 3.629.291 |
| 2026-02-19 | 35.325 | 99,79 | 3.525.082 |
| 2026-02-18 | 10 | 100,61 | 1.006 |
| 2026-02-11 | 31.194 | 95,98 | 2.994.000 |
| 2026-02-09 | 1 | 97,49 | 97 |
| 2026-02-02 | 99.786 | 96,95 | 9.674.253 |
| 2026-01-30 | 99.785 | 98,20 | 9.798.887 |
| 2026-01-29 | 99.673 | 97,33 | 9.701.173 |
| 2026-01-20 | 200 | 120,28 | 24.056 |
| 2026-01-16 | 6.119 | 123,27 | 754.289 |